John Green

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Silvia Buonamici, Juliet Williams, Michael Morrissey et al. · Science Translational Medicine · 2010 · 554 citations

Medicine, Oncology, Pharmacology +16

Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies

Seth A. Ettenberg, Olga Charlat, Shanming Liu et al. · Proceedings of the National Academy of Sciences · 2010 · 153 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Discovery of NVP‐LEQ506, a Second‐Generation Inhibitor of Smoothened

Stefan Peukert, Feng He, Miao Dai et al. · ChemMedChem · 2013 · 88 citations

Medicine, Pharmacokinetics, Pharmacology +15

LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

Kelli‐Ann Monaco, Scott Delach, Jing Yuan et al. · Clinical Cancer Research · 2020 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes

Harnish Duncan, Charles Swanx, John Green et al. · Clinica Chimica Acta · 1995 · 43 citations

Medicine, Genetics, Molecular Genetics +16